303 related articles for article (PubMed ID: 17611719)
1. Capecitabine therapy of central nervous system metastases from breast cancer.
Ekenel M; Hormigo AM; Peak S; Deangelis LM; Abrey LE
J Neurooncol; 2007 Nov; 85(2):223-7. PubMed ID: 17611719
[TBL] [Abstract][Full Text] [Related]
2. Long-term clinical response in leptomeningeal metastases from breast cancer treated with capecitabine monotherapy: a case report.
Tham YL; Hinckley L; Teh BS; Elledge R
Clin Breast Cancer; 2006 Jun; 7(2):164-6. PubMed ID: 16800978
[TBL] [Abstract][Full Text] [Related]
3. Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy.
Rogers LR; Remer SE; Tejwani S
Neuro Oncol; 2004 Jan; 6(1):63-4. PubMed ID: 14769142
[TBL] [Abstract][Full Text] [Related]
4. Response of neoplastic meningitis from solid tumors to oral capecitabine.
Giglio P; Tremont-Lukats IW; Groves MD
J Neurooncol; 2003 Nov; 65(2):167-72. PubMed ID: 14686737
[TBL] [Abstract][Full Text] [Related]
5. Potential role of chemo-radiation with oral capecitabine in a breast cancer patient with central nervous system relapse.
Hikino H; Yamada T; Johbara K; Obayashi N; Ozaki N
Breast; 2006 Feb; 15(1):97-9. PubMed ID: 16005228
[TBL] [Abstract][Full Text] [Related]
6. Dramatic response with capecitabine after cranial radiation to the brain parenchymal and leptomeningeal metastases from lung cancer.
Paydas S; Bicakci K; Yavuz S
Eur J Intern Med; 2009 Jan; 20(1):96-9. PubMed ID: 19237101
[TBL] [Abstract][Full Text] [Related]
7. Capecitabine after anthracycline and taxane exposure in HER2-negative metastatic breast cancer patients: response, survival and prognostic factors.
Gilabert M; Bertucci F; Esterni B; Madroszyk A; Tarpin C; Jacquemier J; Extra JM; Viens P; Gonçalves A
Anticancer Res; 2011 Mar; 31(3):1079-86. PubMed ID: 21498742
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors for efficacy of capecitabine in heavily pretreated patients with metastatic breast cancer.
Osako T; Ito Y; Ushijima M; Takahashi S; Tokudome N; Sugihara T; Iwase T; Matsuura M; Hatake K
Cancer Chemother Pharmacol; 2009 Apr; 63(5):865-71. PubMed ID: 18670777
[TBL] [Abstract][Full Text] [Related]
9. Lack of prognostic value of mean corpuscular volume with capecitabine therapy in metastatic breast cancer.
Bozkurt O; Berk V; Kaplan MA; Cetin B; Ozaslan E; Karaca H; Inanc M; Duran AO; Ozkan M
Asian Pac J Cancer Prev; 2014; 15(6):2501-4. PubMed ID: 24761854
[TBL] [Abstract][Full Text] [Related]
10. Capecitabine for 5-fluorouracil-resistant brain metastases from breast cancer.
Wang ML; Yung WK; Royce ME; Schomer DF; Theriault RL
Am J Clin Oncol; 2001 Aug; 24(4):421-4. PubMed ID: 11474279
[TBL] [Abstract][Full Text] [Related]
11. Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation.
Fabi A; Metro G; Papaldo P; Mottolese M; Melucci E; Carlini P; Sperduti I; Russillo M; Gelibter A; Ferretti G; Tomao S; Milella M; Cognetti F
Cancer Chemother Pharmacol; 2008 Sep; 62(4):717-25. PubMed ID: 18071704
[TBL] [Abstract][Full Text] [Related]
12. Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.
Bendell JC; Domchek SM; Burstein HJ; Harris L; Younger J; Kuter I; Bunnell C; Rue M; Gelman R; Winer E
Cancer; 2003 Jun; 97(12):2972-7. PubMed ID: 12784331
[TBL] [Abstract][Full Text] [Related]
13. Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer.
Blum JL; Barrios CH; Feldman N; Verma S; McKenna EF; Lee LF; Scotto N; Gralow J
Breast Cancer Res Treat; 2012 Dec; 136(3):777-88. PubMed ID: 23104222
[TBL] [Abstract][Full Text] [Related]
14. Dramatic regression of multiple brain metastases from breast cancer with Capecitabine: another arrow at the bow?
Fabi A; Vidiri A; Ferretti G; Felici A; Papaldo P; Carlini P; Mirri A; Nuzzo C; Cognetti F
Cancer Invest; 2006; 24(4):466-8. PubMed ID: 16777702
[TBL] [Abstract][Full Text] [Related]
15. [Long-term response of liver metastases of breast cancer to capecitabine--case report].
Macková D
Klin Onkol; 2010; 23(1):46-8. PubMed ID: 20192074
[TBL] [Abstract][Full Text] [Related]
16. Complete response of brain metastases originating in breast cancer to capecitabine therapy.
Siegelmann-Danieli N; Stein M; Bar-Ziv J
Isr Med Assoc J; 2003 Nov; 5(11):833-4. PubMed ID: 14650117
[No Abstract] [Full Text] [Related]
17. Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology.
Kaplan MA; Isikdogan A; Koca D; Kucukoner M; Gumusay O; Yildiz R; Dayan A; Demir L; Geredeli C; Kocer M; Arslan UY; Inal A; Akman T; Coskun U; Sener N; Inanc M; Elkiran ET; Ozdemir NY; Durnalı AG; Suner A; Alici S; Tarhan MO; Boruban C; Oksuzoglu B; Urakci Z
Breast Cancer; 2014 Nov; 21(6):677-83. PubMed ID: 23335064
[TBL] [Abstract][Full Text] [Related]
18. Ixabepilone plus capecitabine for breast cancer patients with an early metastatic relapse after adjuvant chemotherapy: two clinical trials.
Fornier M
Clin Breast Cancer; 2010 Oct; 10(5):352-8. PubMed ID: 20920979
[TBL] [Abstract][Full Text] [Related]
19. Final results of an international retrospective observational study in patients with advanced breast cancer treated with oral vinorelbine-based chemotherapy.
Palomo AG; Glogowska I; Sommer H; Malamos N; Kilar E; Vega JM; Torrecillas L; Delozier T; Ettl J; Finek J
Anticancer Res; 2012 Oct; 32(10):4539-45. PubMed ID: 23060583
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic efficacy of capecitabine on advanced and recurrent breast cancer with special reference to time to progression].
Shiiki S; Sonoo H; Seki M; Nomura T; Hironou M; Ookubo S; Udagawa K; Yamamoto Y; Nakashima K; Ikeda M; Tanaka K; Kurebayashi J
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1431-5. PubMed ID: 17033232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
